Back to School: How biopharma can reboot drug development. Access exclusive analysis here

Syrrx, Roche cancer, metabolic deal

Syrrx (San Diego, Calif.) and Roche (SWX:ROCZ) partnered to discover and develop

Read the full 121 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE